Close

Amarin Corp. (AMRN) Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024 Jan 10, 2024 07:02AM
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024 Jan 10, 2024 07:00AM
Greater Competition Does Not Impact Investment Thesis - Cantor Fitzgerald Reiterates Amarin Corporation (AMRN)at Overweight Jun 22, 2022 05:44PM
Cantor Fitzgerald Reiterates Amarin Corporation (AMRN) at Overweight, "Street is Underestimating Multi-billion Dollar Opportunity for Vascepa/Vazkepa" Mar 1, 2022 10:35AM
Amarin to Participate in September Investment Conferences Sep 13, 2021 06:00AM
View Older Stories

Sep 13, 2021 06:00AM Amarin to Participate in September Investment Conferences
Jun 11, 2021 08:10AM Amarin Corporation (AMRN) Symphony Data Shows Vacepta in Uptrend - Cantor Fitzgerald
Apr 16, 2021 08:12AM Amarin Corporation's (AMRN) Vascepta Symphony Health Numbers are Increasing Meaningfully - Cantor Fitzgerald
Mar 5, 2021 10:55AM Cantor Reiterates Overweight on Amarin (AMRN) as Recent Concerns are 'Overdone'
Jan 22, 2021 09:23AM Pre-Open Stock Movers 01/22: (ADMP) (CLII) (SCYX) Higher; (PGEN) (IBM) (GSL) Lower (more...)
Jan 21, 2021 05:27PM After-Hours Stock Movers 01/21: (ADMP) (IBIO) (FLDM) Higher; (PGEN) (IBM) (GSL) Lower (more...)
Dec 28, 2020 08:11AM Amarin Corporation (AMRN) Symphony Data Shows Continuing Improvement - Cantor Fitzgerald
Aug 4, 2020 12:22PM Amarin (AMRN) Retaining EU Rights 'The Right Thing to Do' - Cantor Fitzgerald
Jul 9, 2020 04:55PM Cantor Fitzgerald Said Amarin (AMRN) NDR Supports Bullish Rating, PT
Jul 8, 2020 07:25AM Companies with NDRs 7/08
Jun 15, 2020 12:01PM Amarin (AMRN) Continues to Offer 'Sweets' - Cantor Fitzgerald
Apr 14, 2020 07:07AM Cantor Fitzgerald Reiterates Overweight Rating on Amarin Corporation (AMRN) Following Conference Call
Jan 13, 2020 07:23AM Two Pieces of Good News for Amarin (AMRN) - Cantor Fitzgerald
Jan 8, 2020 11:56AM Cantor Fitzgerald Defends Amarin (AMRN), Says Headlines 'Noise'
Jan 8, 2020 06:50AM Amarin Corporation (AMRN) Updated Guidance In Line, Cantor Fitzgerald Reiterates Outperform
Jan 7, 2020 07:42AM Amarin Corporation (AMRN) Expenses May Drive Expenses Higher but Vascepa Peak Sales Remains the Key for Investors - Cantor Fitzgerald
Jan 2, 2020 10:34AM Health Canada Approval Underscores Global Market Opportunity for Amarin's (AMRN) Vascepa - Cantor Fitzgerald
Dec 20, 2019 08:53AM Amarin's (AMRN) Vascepa Rxs Continue To Show Positive Trends - Cantor Fitzgerald
Dec 2, 2019 11:16AM Amarin (AMRN) Vascepa Checks Another Box with EMA Acceptance - Cantor Fitzgerald
Nov 14, 2019 05:49PM Cantor Fitzgerald Expects Shares of Amarin (AMRN) to Rise After 16-0 Favorable FDA Adcom Vote
Nov 6, 2019 07:08AM Amarin Corporation (AMRN) Beats but Vascepa Remains Underappreciated - Cantor
Oct 29, 2019 03:04PM Cantor Fitzgerald Positive on Amarin (AMRN) As Generics Lose On Summary Judgement
Oct 17, 2019 12:17PM Cantor Fitzgerald Reiterates Positive View on Amarin (AMRN) Following Final ICER Report
Sep 20, 2019 08:01AM Amarin Corporation (AMRN) Symphony Data On An Uptrend - Cantor Fitzgerald
Sep 16, 2019 10:32AM NLA Provides Amarin's (AMRN) Vascepa With Yet Another Positive Recommendation - Cantor Fitzgerald
Sep 11, 2019 10:35AM Visibility on Amarin (AMRN) sNDA Removes Overhang - Cantor Fitzgerald
Sep 3, 2019 07:53AM Amarin Corporation (AMRN): AdCom and sNDA Concerns are Overdone - Cantor Fitzgerald
Aug 15, 2019 07:11AM Amarin Corporation (AMRN) Reiterated Overweight At Cantor Fitzgerald
Aug 9, 2019 09:12AM Amarin Corporation (AMRN) - Negative Reaction To AdCom Is Overdone - Cantor
Jul 31, 2019 10:43AM Cantor Fitzgerald Reiterates Overweight Rating on Amarin Corporation (AMRN)
Jul 29, 2019 05:17PM Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
Jul 29, 2019 05:17PM Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
Jul 24, 2019 09:57AM Cantor Fitzgerald Notes Amarin (AMRN) Pharmacoeconomic Analysis Results 'Is ICER-ing On The Cake'
Jul 24, 2019 07:08AM Amarin Corporation's (AMRN) Peak Sales Could Exceed Great Expectations - Cantor
Jul 19, 2019 05:36AM Amarin Corp. (AMRN) Prices 22.22M ADS Offering at $18/ADS
Jul 18, 2019 11:47PM Amarin Prices Public Offering of American Depositary Shares
Jul 18, 2019 11:47PM Amarin Prices Public Offering of American Depositary Shares
Jul 17, 2019 04:02PM Amarin Corp. (AMRN) Announces Proposed $400M ADS Offering
Jul 17, 2019 04:01PM Amarin Announces $400,000,000 Public Offering of American Depositary Shares
Jul 17, 2019 04:01PM Amarin Announces $400,000,000 Public Offering of American Depositary Shares
Jul 12, 2019 09:02AM Amarin Corporation (AMRN) Should Benefit from Strong Vascepta Script Data - Cantor
Jul 11, 2019 08:49AM Amarin Corporation (AMRN) Scripts May Be Underrepresented By Script Data - Cantor
Jul 2, 2019 08:20AM Cantor Fitzgerald Reiterates Overweight Rating on Amarin Corporation (AMRN)
Jun 14, 2019 09:00AM Amarin (AMRN) Vascepa RXs Outpace Industry as of 06/07 - Cantor Fitzgerald
May 31, 2019 08:46AM Cantor Fitzgerald Reiterates Overweight Rating on Amarin (AMRN) Following Latest Vascepa Rxs
May 29, 2019 07:19AM Cantor Fitzgerald Reiterates Overweight Rating on Amarin (AMRN) Following Priority Review
Mar 29, 2019 01:48PM Amarin Corp. (AMRN) Ends Blockbuster Week with a Bang
Mar 28, 2019 07:15AM Amarin Corporation (AMRN) Inclusion In ADA Standards A Significant Positive - Cantor
Mar 18, 2019 10:58AM Amarin Corporation (AMRN) ACC Presentation Supports Economic Value For Vascepa - Cantor
Jan 11, 2019 07:53AM Amarin (AMRN): Potential Takeout And Positive Rx Trends Support Positive Thesis - Cantor Fitzgerald
View Older Stories